Literature DB >> 35348103

Rates of Acute Myocardial Infarction During the COVID-19 Pandemic.

Matthew T Mefford1, Jaejin An1,2, Nigel Gupta3, Teresa N Harrison1, Steven J Jacobsen1,2, Ming-Sum Lee4, Paul Muntner1,5, Chileshe Nkonde-Price6,7, Lei Qian1, Kristi Reynolds1,2.   

Abstract

BACKGROUND: During the early phases of the COVID-19 pandemic pandemic, stay-at-home orders and fear of acquiring COVID-19 may have led to an avoidance of care for medical emergencies, including acute myocardial infarction (AMI). We evaluated whether a decline in rates of AMI occurred during the COVID-19 stay-at-home order.
METHODS: Rates of AMI per 100,000 member-weeks were calculated for Kaiser Permanente Southern California patients from January 1 to March 3, 2020 (prepandemic period) and from March 20 to July 31, 2020 (pandemic period), and during the same periods in 2019. Rate ratios (RRs) were calculated comparing the time periods using Poisson regression. Case fatality rates (CFRs) were also compared.
RESULTS: Rates of AMI were lower during the pandemic period of 2020 compared to the same period of 2019 [3.20 vs 3.76/100,000 member-weeks; RR, 0.85; 95% confidence interval (CI) 0.80-0.90]. There was no evidence that rates of AMI differed during the 2020 prepandemic period compared to the same period in 2019 (4.45 vs 4.24/100,000 member-weeks; RR, 0.95; 95% CI, 0.88-1.03). AMI rates were lower during the early pandemic period (March 20-May 7: RR, 0.70; 95% CI, 0.66-0.77), but not during the later pandemic period (May 8-July 31: RR, 0.95; 95% CI, 0.88-1.02) compared to 2019. In-hospital and 30-day case fatality rates were higher during the pandemic period of 2020 compared to 2019 (8.8% vs 6.1% and 6.5% vs 5.0%, respectively).
CONCLUSION: AMI rates were lower during the COVID-19 pandemic compared to the same period in 2019. During stay-at-home orders, public health campaigns that encourage people to seek care for medical emergencies are warranted.

Entities:  

Mesh:

Year:  2021        PMID: 35348103      PMCID: PMC8784080          DOI: 10.7812/TPP/21.074

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  18 in total

1.  The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.

Authors:  Matthew D Solomon; Edward J McNulty; Jamal S Rana; Thomas K Leong; Catherine Lee; Sue-Hee Sung; Andrew P Ambrosy; Stephen Sidney; Alan S Go
Journal:  N Engl J Med       Date:  2020-05-19       Impact factor: 91.245

2.  Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England: Insights From the British Cardiovascular Intervention Society PCI Database Cohort.

Authors:  Chun Shing Kwok; Chris P Gale; Nick Curzen; Mark A de Belder; Peter Ludman; Thomas F Lüscher; Evangelos Kontopantelis; Chris Roebuck; Tom Denwood; Tony Burton; Julian Hains; John E Deanfield; Mamas A Mamas
Journal:  Circ Cardiovasc Interv       Date:  2020-11-03       Impact factor: 6.546

3.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

4.  Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data.

Authors:  Corinna Koebnick; Annette M Langer-Gould; Michael K Gould; Chun R Chao; Rajan L Iyer; Ning Smith; Wansu Chen; Steven J Jacobsen
Journal:  Perm J       Date:  2012

5.  Impact of the COVID-19 Pandemic on Emergency Department Visits - United States, January 1, 2019-May 30, 2020.

Authors:  Kathleen P Hartnett; Aaron Kite-Powell; Jourdan DeVies; Michael A Coletta; Tegan K Boehmer; Jennifer Adjemian; Adi V Gundlapalli
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-12       Impact factor: 17.586

Review 6.  Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak.

Authors:  Raffaele Piccolo; Dario Bruzzese; Ciro Mauro; Antonio Aloia; Cesare Baldi; Marco Boccalatte; Giuseppe Bottiglieri; Carlo Briguori; Gianluca Caiazzo; Paolo Calabrò; Maurizio Cappelli-Bigazzi; Ciro De Simone; Emilio Di Lorenzo; Paolo Golino; Vittorio Monda; Rocco Perrotta; Gaetano Quaranta; Enrico Russolillo; Marino Scherillo; Tullio Tesorio; Bernardino Tuccillo; Giuseppe Valva; Bruno Villari; Giuseppe Tarantini; Attilio Varricchio; Giovanni Esposito
Journal:  Circulation       Date:  2020-04-30       Impact factor: 29.690

7.  Cardiovascular Deaths During the COVID-19 Pandemic in the United States.

Authors:  Rishi K Wadhera; Changyu Shen; Suhas Gondi; Siyan Chen; Dhruv S Kazi; Robert W Yeh
Journal:  J Am Coll Cardiol       Date:  2021-01-19       Impact factor: 24.094

8.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.

Authors:  Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry
Journal:  J Am Coll Cardiol       Date:  2020-04-10       Impact factor: 24.094

9.  Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.

Authors:  Bernhard Metzler; Peter Siostrzonek; Ronald K Binder; Axel Bauer; Sebastian Johannes Reinstadler
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

10.  Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.

Authors:  Jianhua Wu; Mamas A Mamas; Mark A de Belder; John E Deanfield; Chris P Gale
Journal:  J Am Coll Cardiol       Date:  2021-01-19       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.